Overview: BK Virus Qualitative PCR TestIntroduction: The BK Virus Qualitative PCR Test detects BK virus, linked to kidney transplant complications, causing kidney dysfunction or urinary issues. Following 2023 AST guidelines, it uses PCR for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in virology for kidney transplant patients.
Other Names: BK Virus PCR Assay, Transplant Viral Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: BK virus testing began in the 1990s with transplant research. PCR assays emerged in the 2000s, and by the 2010s, qualitative PCR improved viral detection.
Purpose: Diagnoses BK virus infection, guides treatment, and monitors transplant patients with kidney dysfunction or urinary issues.
Test Parameters: 1. BK Virus DNA
Pretest Condition: No fasting required. Collect swab, sputum, body fluid, plasma, urine, or saliva at any time. Report symptoms like urinary issues or transplant history.
Specimen: 1-2 swabs (sterile swab/transport medium), 5-10 mL sputum (sterile container), 5-10 mL body fluid (sterile container), 2-4 mL plasma (EDTA), 5-20 mL urine (sterile container), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document transplant history, kidney dysfunction, or urinary symptoms. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy.
Procedural Considerations: Uses PCR to detect BK virus DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Improper storage or delayed transport can degrade DNA. Immunosuppressants may affect viral load detection.
Clinical Significance: Positive results confirm BK virus infection, prompting antiviral therapy or immunosuppression adjustment. Negative results may require quantitative PCR.
Specialist Consultation: Consult a nephrologist for result interpretation. An infectious disease specialist referral is advised for treatment planning.
Additional Supporting Tests: BK virus quantitative PCR, kidney function tests, or renal biopsy to confirm infection or assess kidney damage.
Test Limitations: False negatives may occur with low viral loads. Results require clinical correlation.
References: AST Transplant Guidelines, 2023; American Journal of Transplantation, Hirsch HH, 2022.
